Feb 6, 2024, 09:01 by

Quantify Research has announced the opening of its new office today in Helsinki, Finland.

Feb 6, 2024, 09:01 by

Datavant’s privacy-preserving record linkage technology will allow Verisense Health’s digital health data to generate richer patient insights.

Feb 6, 2024, 09:01 by

Azenta Life Sciences has announced that it will display a range of productivity-enhancing consumables, instruments, and automated sample storage products at SLAS 2024 in Boston, USA from February 5 - 7.

Feb 6, 2024, 01:00 by User Not Found

Clinical Research News | Investigators with The University of New Mexico (UNM) and the National Institutes of Health (NIH) have succeeded in developing a cholesterol-lowering vaccine that works independently of statins. It could become the next vaccine-based approach targeting PCSK9 (proprotein convertase subtilisin/kexin type 9 serine protease) to enter clinical trials.

Feb 5, 2024, 09:02 by

Greenphire, a leading innovator in software solutions for streamlining clinical trials, proudly announces the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials. This strategic move is poised to revolutionize the landscape of clinical trial support services by integrating unparalleled patient care with cutting-edge technology.

Feb 2, 2024, 13:04 by User Not Found

Clinical Research News | Yesterday, Greenphire, an innovator in clinical trials software, announced the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials.

Feb 2, 2024, 09:20 by

NADMED has announced an innovative technology designed for effortless extracting and measuring all four NADs and two glutathiones.

Feb 2, 2024, 09:20 by

Feb 2, 2024, 09:20 by

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials

Feb 1, 2024, 08:51 by

Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers unparalleled depth in immune system analysis, advancing immunology, virology, autoimmunity, and allergy research, providing new disease insights, and discovering new biomarkers and treatments. The MIPSA technology exploits recent advances in high throughput DNA sequencing and DNA synthesis, to create and analyze the most complete panels of immune targets available.

Feb 1, 2024, 01:00 by User Not Found

Clinical Research News | A clinical-grade smartwatch does a good job of detecting possible atrial fibrillation (AFib), which could fill the need for a noninvasive option for monitoring patients for more than 30 days. Current available electrocardiography (ECG) technologies, such as Holter monitors and wearable event recorders, are both more time-limited and resource-intensive.

Jan 31, 2024, 01:00 by User Not Found

Diagnostics World | Illumina Ventures Labs is now operational and finalizing agreements with several startup companies; the Personalized Medicine Coalition has released their Strategic Plan for Advancing Personalized Medicine in 2024; Imagine Pharma announced the formation of The Imagine Pharma Foundation, a private not for profit charitable organization dedicated to advancing metabolic research to significantly impact the lives of those affected by diabetes, with a particular emphasis on serving veterans; several collaborations and partnerships have been formed to tackle trials, studies, and research; more.

Jan 30, 2024, 08:50 by

Jan 30, 2024, 08:50 by

Jan 30, 2024, 01:00 by User Not Found

Clinical Research News | Newcastle University, University of Edinburgh, and Boehringer Ingelheim have received funding to begin the most extensive clinical study into liver cirrhosis ever; the University of New England has received an award from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence to be named the UNE Center for Cell Signaling Research; Oxitope Pharma and Arxx Therapeutics have merged to form Calluna Pharma Inc. (Calluna) and intend to work on a pipeline of selective antibodies that target inflammatory and fibrotic indications; more.

Jan 29, 2024, 08:33 by

Jan 29, 2024, 08:33 by

Jan 29, 2024, 08:33 by

Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare

Jan 29, 2024, 08:33 by

Jan 29, 2024, 08:33 by

CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.